Tissue Regenix Group plc TSSNF OTC

Other OTC • Healthcare • Biotechnology • GB • USD

SharesGrow Score

44/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Tissue Regenix Group plc (TSSNF) reported total assets of $45.35M and total liabilities of $16.29M for fiscal year 2024, resulting in total equity of $29.06M.

The company held $1.87M in cash and short-term investments. Total debt stood at $10.47M, with net debt of $8.6M. The Debt-to-Equity (D/E) ratio was 0.36 (conservative).

Current ratio is 3.46, indicating strong short-term liquidity. Interest coverage is 0.4x (weak).

Criteria supported by this page:

HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
MOAT (43/100) — Total assets $45.35M and equity $29.06M support the company's competitive scale

Overall SharesGrow Score: 41/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

44/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

43/100

→ Income

✓

GROWTH

100/100

→ Income

✗

INCOME

10/100

→ Income

Tissue Regenix Group plc Balance Sheet History

Metric	FY2024	FY2023	FY2022	FY2021
Total Assets	$45.35M	$43.24M	$38.27M	$46.22M
Total Liabilities	$16.29M	$13.89M	$13M	$12.83M
Total Debt	$10.47M	$9.4M	$7.99M	$7.95M
Cash & Investments	$1.87M	$4.65M	$4.95M	$7.71M
Total Stockholders Equity	$29.82M	$30.15M	$25.98M	$34.34M